May 12, 2026 09:58AM
Dec 8, 2025 07:00AM
Sep 3, 2024 07:00AM
Sep 5, 2023 04:05PM
Dec 5, 2022 08:31AM
Dec 5, 2022 08:30AM
Sep 7, 2022 07:00AM Karyopharm to Participate at Upcoming Investor Conferences
Sep 7, 2021 07:00AM
Nov 3, 2020 09:21AM
Sep 2, 2020 07:00AM
Mar 6, 2020 04:05PM
Mar 4, 2020 05:54AM
Mar 3, 2020 06:36PM
Mar 2, 2020 08:29AM Karyopharm Therapeutics (KPTI) PT Raised to $35 at Baird
Nov 13, 2019 07:10AM
Sep 24, 2019 07:17AM
Sep 16, 2019 09:58AM
Aug 28, 2019 07:00AM
Aug 28, 2019 07:00AM
Jul 5, 2019 06:32AM
Jul 5, 2019 06:26AM Karyopharm Therapeutics (KPTI) PT Raised to $25 at Baird
Feb 27, 2019 06:37AM
Aug 29, 2018 07:00AM
Aug 29, 2018 07:00AM
Aug 7, 2018 01:52PM
Jun 15, 2018 12:47PM
May 24, 2018 09:23AM
May 10, 2018 12:38PM Karyopharm Therapeutics (KPTI) Momentum is Building - Baird
May 7, 2018 04:05PM
May 7, 2018 04:05PM
May 3, 2018 05:37AM
May 2, 2018 09:46PM
May 2, 2018 09:46PM
May 1, 2018 04:41PM
May 1, 2018 04:33PM Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
May 1, 2018 04:33PM
Mar 15, 2018 02:01PM
Oct 12, 2017 11:16AM
Aug 30, 2017 07:00AM
Apr 25, 2017 09:29AM
Apr 24, 2017 06:13PM
Apr 4, 2017 04:46PM Baird Reiterates Outperform Rating and $15 PT on Karyopharm Therapeutics (KPTI); 'Phase 2b SADAL Data Demonstrate Durable Response in DLBCL'
Sep 6, 2016 10:08AM
Jun 28, 2016 10:48AM
Jun 27, 2016 04:04PM

27,766 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All